CGON
CG Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$74.62
−1.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 176.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.43x
- Price / sales
- 1062.03x
- Price / cash flow
- -37.06x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 898.34x
- EV / EBITDA
- -25.17x
- EV / EBIT
- -22.15x
- Market cap
- $6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026